In the next step, the researchers want to develop new molecules based on digoxin that are even better at dissolving the CTC clusters.

Katie Elson is not yet 30. In early 2022 her partner noticed a small lump in her breast. At first they thought it was an ...

Study Reveals Intensive Blood Pressure Control Reduces Risk of Cognitive ImpairmentA new study shows that only 3½ years of ...

This is not the first time lawmakers have pushed to change state laws requiring approval from insurance companies for ...

Patients with metastatic colorectal cancer (mCRC) harboring BRAF V600E mutations benefited from first-line treatment with the targeted therapies encorafenib and cetuximab plus a mFOLFOX6 chemotherapy ...

More than Pink Walk brings in thousands of people for breast cancer awareness. A sea of pink filled the streets of Downtown ...

Pfizer Inc. today announced positive results from the Phase 3 BREAKWATER trial evaluating BRAFTOVI® (encorafenib) in combination with cetuximab (marketed as ERBITUX®) and mFOLFOX6 (fluorouracil, ...

Those who knew Bridgette Hempstead describe her as a warrior for Africa-American women diagnosed with breast cancer.

SELLAS Life Sciences CEO Angelos Stergiou and "Some Future Day" author Marc Beckman predict artificial intelligence will ...

Natera, Inc. , a global leader in cell-free DNA and genetic testing, announced new data from the randomized, Phase III CALGB (Alliance) / SWOG 80702 study. The study will be presented today, Jan. 25, ...

The former Kate Middleton was diagnosed with cancer early in 2024, and much speculation about the state of her health has followed. Catherine, Princess of Wales, has since shared that she ...

Pete Hegseth Is Sworn In as Defense Secretary After Being Confirmed by Slim Margin Mr. Hegseth has vowed to bring his “warrior” ethos to the Pentagon. His confirmation came down to Vice ...